Procter & Gamble officer Matthew W. Janzaruk filed a Form 144 notice on November 2, 2026, proposing the sale of 9,479 shares of common stock via stock option exercise on or around November 3, 2026.

Key Highlights

  • Proposed sale: 9,479 shares of Procter & Gamble common stock, with an aggregate market value of $1,546,925.41, based on the average of the high and low price on October 30, 2026.
  • Acquisition method: The shares are to be acquired through exercise and sale of a stock option from The Procter & Gamble Company, with both acquisition and payment dates listed as November 3, 2026.
  • Executing broker: Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 38th Floor, New York, NY 10004.
  • Shares outstanding: According to the filing, 2,317,783,143 shares of common stock were outstanding at the time of filing.
  • Prior sales in past 3 months: Janzaruk sold 359 shares on August 24, 2026, for gross proceeds of $52,141.16, and 156 shares on August 20, 2026, for gross proceeds of $22,431.24.
  • Exchange listed: NYSE, consistent with Procter & Gamble's listing as referenced in the filing.

Matthew W. Janzaruk's Proposed Stock Option Exercise and Sale at Procter & Gamble

According to the Form 144 filed with the U.S. Securities and Exchange Commission on November 2, 2026, Matthew W. Janzaruk, identified as an officer of Procter & Gamble Co (NYSE:PG), intends to sell 9,479 shares of the company's common stock. The notice was signed by Aaron B. Shepherd as attorney-in-fact for Janzaruk. The filing states that the aggregate market value of the proposed sale is $1,546,925.41, calculated using the average of the high and low price on October 30, 2026.

The filing indicates the shares will be obtained through the exercise and sale of a stock option granted by The Procter & Gamble Company, with both the acquisition date and payment date listed as November 3, 2026. Payment is described as cash. The proposed transaction is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, 38th Floor, New York, NY 10004.

The filing also discloses Janzaruk's sales activity over the prior three months. On August 20, 2026, he sold 156 shares for gross proceeds of $22,431.24, and on August 24, 2026, he sold 359 shares for gross proceeds of $52,141.16. The total shares of Procter & Gamble common stock outstanding are listed in the filing as 2,317,783,143. The Procter & Gamble Company is headquartered at One Procter & Gamble Plaza, Cincinnati, Ohio 45202, with SEC File Number 001-00434.

What Was Disclosed

A Form 144 notice was filed on November 2, 2026, by officer Matthew W. Janzaruk, proposing the sale of 9,479 Procter & Gamble common shares via stock option exercise, with an aggregate market value of $1,546,925.41, scheduled for November 3, 2026.